PureTech Health announces first patient dosing in Celea phase 3 trial
13th Jul 2026 10:17
(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More
(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More
(Alliance News) - ME Group International PLC on Monday said trading picked up in May and June after a subdued April, as it reiterated recently reduced annual profit guidance. Read More
(Alliance News) - GSK PLC on Monday reported encouraging trial data for its cancer treatment Jemperli, also known as dostarlimab. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
(Alliance News) - PageGroup PLC on Monday hailed a "good performance" in its second quarter, helped by growth growth in the Asia Pacific and Americas regions. Read More
(Alliance News) - Stock prices in London opened slightly lower on Monday as renewed tensions between the US and Iran lifted oil prices. Read More
(Alliance News) - Shares in Oxford Nanopore Technologies PLC on Monday sank as it forecast revenue for the first half of the financial year below market expectations mainly reflecting soft trading in China and the Middle East. Read More
(Alliance News) - Plus500 Ltd shares fell early Monday in London, despite reporting a "record" first-half performance and promising to announce new shareholder returns with the company's interim results, as business growth slowed in the second quarter. Read More
(Alliance News) - Grafton Group PLC on Monday reported a rise in first-half revenue and backed profit guidance for 2026. Read More
(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger traffic edged higher despite a June decline caused by weaker Middle East travel. Read More
Phoenix Copper Ltd - developing Empire copper, gold and silver mine in the US state of Idaho - Appeals to shareholders to allow its equity raise to go forward in their voting at the company's annual general meeting on July 24, despite a scandal involving the company's former executive chair and chief financial officer. Early last week, Phoenix said it raised GBP2.4 million from a share placing with institutional investors and subscription by Phoenix directors, selling 489.2 million shares at 0.50 pence each. However, a retail share offer to raise up to a further GBP500,000 raised only GBP67,218, Phoenix said on Friday. To allow the equity raise to be completed, Phoenix needs shareholders to support a special resolution at the AGM to dis-apply their pre-emption rights. Read More
Schroder European Real Estate Investment Trust PLC - London and Johannesburg-listed property investor - Says its property portfolio is independently valued at EUR185.1 million on June 30, the end of its financial third quarter, down 3.9% from EUR192.6 million on March 31. On year, the property value is down 4.5% from EUR193.9 million. The REIT says the decline in property value reflects weaker investment demand, particularly for secondary offices, driven by heightened macroeconomic uncertainty, alongside inflation and interest rate concerns. Read More
(Alliance News) - MasterCard Inc is considering selling a majority holding in UK payments business Vocalink, the Financial Times reported early on Monday. Read More
(Alliance News) - Stocks in London are set to open lower on Monday as renewed tensions in the Middle East pushed oil prices higher and weighed on investor sentiment. Read More
(Alliance News) - Segro PLC Chief Executive David Sleath has vowed to remain at the helm of the warehouse and data centre developer as he fights off a GBP12.6 billion hostile takeover approach from US rival ProLogis Inc, according to an interview with The Sunday Times. Read More